JNJ vs GILD
By Alex · Tickerpine
Johnson & Johnson vs Gilead Sciences, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | JNJ | GILD |
|---|---|---|
| Price | $254.66 | $127.88 |
| Market cap | $613.02B | $158.77B |
| P/E ratio | 29.5 | 17.4 |
| ROE | 26.42% | 43.36% |
| Profit margin | 21.83% | 30.99% |
| Revenue growth | 9.90% | 4.40% |
| Dividend yield | 2.10% | 2.56% |
| Beta | 0.26 | 0.33 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
JNJ vs GILD in plain English
- JNJ is the bigger company — about 3.9× the market cap of GILD.
- GILD is cheaper on earnings (P/E 17.4 vs 29.5).
- GILD earns a higher return on equity (43% vs 26%).
- JNJ is growing revenue faster (10% vs 4%).
- GILD has the higher dividend yield (2.56% vs 2.10%).
How would $1,000 have done in each?
JNJ return calculator
See what $1,000 in Johnson & Johnson would be worth today.
GILD return calculator
See what $1,000 in Gilead Sciences, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.